Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司
For research, development and manufacturing use only. Not for human or veterinary use.

Research Supplies & Solvents · Source-reviewed dossier

Vitamin B-12

Source-Reviewed Research Dossier

Vitamin B-12 in this catalog refers to a cyanocobalamin research solution. DailyMed labeling for regulated cyanocobalamin injection identifies a sterile solution and shows that concentration, preservatives, pH and route belong to the finished formulation. Those labeling details do not automatically apply to this research-use catalog lot.

Research use only Lot documents on request
Vitamin B-12 research product family with 1 catalog variants
AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.

Product family

Compound overview

Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.

Product identity

Product type
Small-molecule research compound
Catalog family
Vitamin B-12
Research category
Research Supplies & Solvents
Catalog CAS RN
68-19-9
Catalog molecular formula
C63H88CoN14O14P
Catalog molecular weight
1355.37 g/mol
Evidence status
Established compound biology and authoritative finished-product labeling
Intended use
Research, development and manufacturing use only

Literature reference parameters

Compound or material class
Cyanocobalamin solutionCatalog-family identity
Evidence scope
Established compound biology and authoritative finished-product labelingDo not generalize beyond the cited model
Source review
Primary or authoritative records linked belowChecked 2026-09-01

Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.

Mechanism of action

How Vitamin B-12 is studied

A target-to-pathway view grounded in the linked research records.

Cobalamin cofactor biology

Vitamin B12 participates in methionine synthase and methylmalonyl-CoA mutase pathways; cyanocobalamin is one supplied chemical form.

Evidence and material boundary

Clinical deficiency treatment and regulated injection labels concern specified medicines. They do not establish the concentration, sterility or suitability of this catalog material.

Reported research findings

What published studies report about Vitamin B-12

Reported outcomes are paired with their experimental model and evidence boundary.

DailyMed label

Finished formulations specify concentration and excipients

The cited cyanocobalamin label describes a sterile solution and provides formulation-specific concentration, preservative and pH information.

It is an authoritative comparison record, not evidence that this catalog lot is the same finished drug.

Read the primary study
Clinical review

Deficiency evidence is distinct from material qualification

A 2022 review summarizes diagnosis and management of vitamin B12 deficiency.

Clinical deficiency guidance does not validate a research reagent or its lot release tests.

Read the primary study
Translation boundary: findings are limited to the evidence level stated on each card. Experimental protocol quantities are research details, not usage instructions.

Catalog options

Variant specifications

Pack-level catalog data; lot-level controls remain document-specific.

Catalog no.B12
Pack size10 mg × 10 vials
Current variant
Specification & documents for B12

Product specification

Small-molecule research compound · 10 mg/vial nominal · 10-vial pack · chemical form, identity and assay controlled by lot specification.

Lot documentation

Request by lot: CoA, identity and assay summary

Quality system

Quality documentation

Document availability is stated honestly and can vary by catalog variant or lot.

Lot-specific Certificate of AnalysisAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Product Specification SheetAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Analytical Method SummaryAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request

Analytical interpretation

Interpret the documents, not just the headline number.

Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.

Open the Quality & Documentation Hub

HPLC area ≠ assayA dominant peak does not establish target mass fraction.

Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.

Counterions affect contentWater, salt form and solvents change the as-is composition.

Storage needs a data basisShipping practice is not the same as stability evidence.

Evidence map

Research context

Published studies and regulatory records, not customer testimonials or usage guidance.

DailyMed label

Finished formulations specify concentration and excipients

It is an authoritative comparison record, not evidence that this catalog lot is the same finished drug.

View primary record
Clinical review

Deficiency evidence is distinct from material qualification

Clinical deficiency guidance does not validate a research reagent or its lot release tests.

View primary record
Evidence boundary: each card states its evidence type. Human trials and regulatory records describe the studied or regulated intervention; preclinical records remain model-specific. None verifies the identity, quality, safety or efficacy of this catalog lot or provides usage instructions.

Literature basis

Curated references

Third-party publications selected for direct relevance.

  1. 01

    Cyanocobalamin Injection, USP

    DailyMed current prescription-drug labeling record.

    Authoritative label
  2. 02

    Vitamin B12 deficiency

    BMJ clinical review. 2022. PMID 35337628.

    Clinical review

Research FAQ

Vitamin B-12 questions

Concise answers for researchers comparing identity, evidence and catalog variants.

What is Vitamin B-12?

Vitamin B-12 in this catalog refers to a cyanocobalamin research solution. DailyMed labeling for regulated cyanocobalamin injection identifies a sterile solution and shows that concentration, preservatives, pH and route belong to the finished formulation. Those labeling details do not automatically apply to this research-use catalog lot.

What evidence is available for Vitamin B-12?

The chemical and physiological roles of cobalamin are established, while formulation attributes must be verified against the catalog specification and lot record.

Does the cited research validate this catalog material?

No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.

Which quality documents can be requested?

A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.

How should Vitamin B-12 be stored?

Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.

Knowledge tools

Continue with structured evidence

Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.

Internal technical source review

Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.

Editorial status: NHD evidence editorial workflow · 2026-09-01 · Not independent medical review · Review policy

Technical procurement

Ready to request a quote?

Selected: B12 · 10 mg × 10 vials